2024, Vol 14, No. 6

Editor-in-Chief

Case Report

1. Acute kidney injury in a patient with metabolic syndrome

Gioacchino Li Cavoli*, Rita Passantino, Angelo Ferrantelli, Angelo Tralongo, Franca Servillo, Tancredi Vincenzo Li Cavoli, Pietro Tralongo, Mattia Palmeri, Giacomo Ferrantelli, Ugo Rotolo

Bioimpacts. 2015;5(3): 155-157. doi: 10.15171/bi.2015.13

PMCID: PMC4597164 PMID: 26457254 Scopus ID: 84944401828

Article

PDF

XML

Cited By:

Original Research

2. Risk association, linkage disequilibrium and haplotype analyses of FASN rs4246445, rs2229425, rs2228305 and rs2229422 polymorphisms in overweight and obesity

Eric Tzyy Jiann Chong , Shawn Shi Erh Kuok, Ping-Chin Lee*

Bioimpacts. 2018;8(3): 159-165. doi: 10.15171/bi.2018.18

PMCID: PMC6128978 PMID: 30211075 Scopus ID: 85050683981

Article

PDF

Full Text

XML

Cited By:

Review

3. Relationship between endocrine disruptors and obesity with a focus on bisphenol A: a narrative review

Sofiane Boudalia* , Aissam Bousbia , Boualem Boumaaza, Malha Oudir, Marie Chantal Canivenc Lavier

BioImpacts. 2021;11(4): 289-300. doi: 10.34172/bi.2021.33

PMCID: PMC8494257 PMID: 34631491 Scopus ID: 85113801724

Article

PDF

Full Text

XML

Cited By:

The use of integrative approaches which mimicking environmental conditions are necessary and recommended to evaluate EDCs' effects in future studies.

Editorial

4. Epigenetics of the blood pressure reactivity to salt: Is the salt sensitive phenotype correctable?

Luigi X Cubeddu*

Bioimpacts. 2023;13(5): 355-358. doi: 10.34172/bi.2023.27552

PMCID: PMC10509743 PMID: 37736342 Scopus ID: 85172786401

Article

PDF

Full Text

XML

Cited By:

Dr. Luigi X. Cubeddu is an MD with a Ph.D. in Pharmacology. Dr. Cubeddu research interests include cardiovasculardrug development, hypertension, and neuroendocrinology.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons